Atlas Trials

Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

Clinical trial NCT05989932 · COMPLETED

Trial details

NCT number
NCT05989932
Sponsor
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse
Status
COMPLETED
Study type
OBSERVATIONAL
Atopic Dermatitis
Start date
2021-12-15
Primary completion
2024-04-19
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.